Lexeo Therapeutics (LXEO) Institutional Ownership $3.06 -0.47 (-13.31%) Closing price 04:00 PM EasternExtended Trading$3.14 +0.07 (+2.45%) As of 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lexeo Therapeutics (NASDAQ:LXEO)CurrentInstitutional OwnershipPercentage60.67%Number ofInstitutional Buyers(last 12 months)46TotalInstitutional Inflows(last 12 months)$57.59MNumber ofInstitutional Sellers(last 12 months)16TotalInstitutional Outflows(last 12 months)$48.40M Get LXEO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LXEO Institutional Buying and Selling by Quarter Lexeo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2025Acadian Asset Management LLC24,648$85K0.0%N/A0.074% 5/16/2025 Woodline Partners LP837,014$2.90M0.0%-2.5%2.521% 5/16/2025 Goldman Sachs Group Inc.79,108$275K0.0%-13.0%0.238% 5/16/2025 Millennium Management LLC1,071,489$3.72M0.0%+654.8%3.228% 5/16/2025 AQR Capital Management LLC50,337$175K0.0%+370.0%0.152% 5/16/2025 Adage Capital Partners GP L.L.C.237,953$826K0.0%-89.2%0.717% 5/15/2025 Vestal Point Capital LP1,136,249$3.94M0.3%-5.3%3.423% 5/15/2025 DAFNA Capital Management LLC378,083$1.31M0.4%-3.8%1.139% 5/14/2025 Affinity Asset Advisors LLC1,480,881$5.14M0.5%N/A4.461% 5/13/2025 Ground Swell Capital LLC23,123$80K0.2%N/A0.070% Get the Latest News and Ratings for LXEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/12/2025 Nuveen LLC36,050$125K0.0%N/A0.109% 5/9/2025 Charles Schwab Investment Management Inc.56,174$195K0.0%-12.1%0.169% 5/9/2025 Privium Fund Management B.V.160,198$556K0.1%+16.0%0.483% 3/24/2025 Wellington Management Group LLP76,981$507K0.0%+48.3%0.233% 2/18/2025 Frazier Life Sciences Management L.P.955,515$6.29M0.3%-23.6%2.889% 2/17/2025 Woodline Partners LP858,691$5.65M0.0%+0.8%2.597% 2/17/2025 Vestal Point Capital LP1,200,000$7.90M0.5%+41.2%3.629% 2/17/2025 Point72 Asset Management L.P.750,235$4.94M0.0%+102.5%2.269% 2/17/2025 Omega Fund Management LLC1,184,636$7.80M6.5%-49.7%3.582% 2/17/2025 Millennium Management LLC141,951$934K0.0%+282.5%0.429% 2/17/2025 Janus Henderson Group PLC4,339,254$28.51M0.0%+15.3%13.121% 2/17/2025 Deutsche Bank AG13,226$87K0.0%+172.8%0.040% 2/17/2025 DAFNA Capital Management LLC393,083$2.59M0.7%+56.9%1.189% 2/17/2025 Corton Capital Inc.13,771$91K0.1%N/A0.042% 2/17/2025 Bridgeway Capital Management LLC65,000$428K0.0%N/A0.197% 2/17/2025 Bank of America Corp DE30,376$200K0.0%-21.7%0.092% 2/17/2025 BNP Paribas Financial Markets34,527$227K0.0%+523.1%0.104% 2/17/2025 Allostery Investments LP5,054$33K0.0%N/A0.015% 2/14/2025 Jane Street Group LLC14,512$95K0.0%-59.3%0.044% 2/14/2025 Northern Trust Corp214,284$1.41M0.0%+7.1%0.648% 2/14/2025 Boothbay Fund Management LLC147,807$973K0.0%+37.5%0.447% 2/14/2025 D1 Capital Partners L.P.2,203,900$14.50M0.2%-12.1%6.664% 2/14/2025 Adage Capital Partners GP L.L.C.2,209,615$14.54M0.0%-14.9%6.682% 2/14/2025 Price T Rowe Associates Inc. MD10,425$69K0.0%N/A0.032% 2/14/2025 Altium Capital Management LLC405,000$2.67M0.8%N/A1.225% 2/13/2025 Marshall Wace LLP17,794$117K0.0%N/A0.054% 2/13/2025 Jump Financial LLC20,400$134K0.0%N/A0.062% 2/13/2025 Walleye Capital LLC61,930$407K0.0%N/A0.187% 2/13/2025 Barclays PLC55,161$363K0.0%+9.9%0.167% 2/13/2025 ADAR1 Capital Management LLC169,505$1.12M0.2%+196.5%0.513% The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a2/13/2025 Aristides Capital LLC29,285$193K0.0%N/A0.089% 2/13/2025 Wells Fargo & Company MN11,156$73K0.0%+49.9%0.034% 2/12/2025 Geode Capital Management LLC567,383$3.74M0.0%+2.6%1.716% 2/12/2025 Wellington Management Group LLP76,981$507K0.0%+48.3%0.233% 2/12/2025 JPMorgan Chase & Co.13,371$88K0.0%+30.1%0.040% 2/11/2025 Privium Fund Management B.V.138,115$909K0.2%N/A0.418% 2/4/2025 Bank of New York Mellon Corp50,660$333K0.0%+5.6%0.153% 1/30/2025 Rhumbline Advisers25,197$166K0.0%+19.6%0.076% 1/24/2025 China Universal Asset Management Co. Ltd.7,011$46K0.0%N/A0.021% 1/17/2025 SG Americas Securities LLC10,960$72K0.0%N/A0.033% 12/26/2024 JPMorgan Chase & Co.10,278$93K0.0%+135.6%0.031% 12/13/2024 Exome Asset Management LLC88,148$797K0.5%N/A0.267% 11/19/2024 Barclays PLC50,210$454K0.0%+162.2%0.152% 11/16/2024 Geode Capital Management LLC553,247$5.00M0.0%+86.5%1.673% 11/15/2024 Frazier Life Sciences Management L.P.1,250,786$11.31M0.5%N/A3.783% 11/15/2024 Barclays PLC50,210$454K0.0%+162.2%0.152% 11/15/2024 Jane Street Group LLC35,677$323K0.0%+33.3%0.108% 11/15/2024 Wellington Management Group LLP51,892$469K0.0%+134.8%0.157% 11/15/2024 State Street Corp253,946$2.30M0.0%+29.4%0.768% 11/15/2024 RA Capital Management L.P.546,554$4.94M0.1%-18.8%1.653% 11/15/2024 Point72 Asset Management L.P.370,407$3.35M0.0%N/A1.120% 11/15/2024 Polar Asset Management Partners Inc.59,800$541K0.0%-8.4%0.181% 11/15/2024 Ikarian Capital LLC257,216$2.33M0.3%N/A0.778% 11/15/2024 Jacobs Levy Equity Management Inc.30,346$274K0.0%N/A0.092% 11/15/2024 Janus Henderson Group PLC3,763,195$34.00M0.0%+18.9%11.383% 11/14/2024 PDT Partners LLC26,608$241K0.0%N/A0.080% 11/14/2024 Braidwell LP728,777$6.59M0.2%-47.3%2.204% 11/14/2024 Eventide Asset Management LLC1,855,986$16.78M0.3%-44.9%5.614% 11/14/2024 Verition Fund Management LLC777,320$7.03M0.0%+84.5%2.351% 11/14/2024 Vestal Point Capital LP850,000$7.68M0.6%+1.2%2.571% 11/14/2024 MetLife Investment Management LLC14,223$129K0.0%+121.5%0.043% 11/13/2024 BNP Paribas Financial Markets5,541$50K0.0%+184.2%0.017% 11/12/2024 Charles Schwab Investment Management Inc.63,874$577K0.0%+107.0%0.193% 10/24/2024 Novo Holdings A S1,122,581$10.15M0.5%-22.6%3.407% 10/23/2024 Values First Advisors Inc.7,446$67K0.0%N/A0.023% 8/20/2024 Novo Holdings A S1,450,500$23.27M1.2%-11.5%4.403% 8/1/2024 Rhumbline Advisers13,357$214K0.0%+37.3%0.041% 7/26/2024 Bank of New York Mellon Corp31,806$510K0.0%+12.3%0.097% 5/17/2024 RA Capital Management L.P.660,938$10.36M0.1%N/A2.006% 5/17/2024 Artal Group S.A.801,716$12.57M0.3%+32.9%2.434% 5/16/2024 Janus Henderson Group PLC2,540,785$39.80M0.0%+9.0%7.713% 5/14/2024 American International Group Inc.5,053$79K0.0%N/A0.015% 5/10/2024 Vanguard Group Inc.481,755$7.55M0.0%+15.8%1.462% 5/1/2024 BNP Paribas Financial Markets4,781$75K0.0%N/A0.015% 4/29/2024Cornell University126,258$1.98M30.0%N/A0.383% 2/20/2024 Eventide Asset Management LLC3,002,831$40.30M0.7%N/A11.268% 2/15/2024 Omega Fund Management LLC2,157,623$28.96M23.5%N/A8.096% 2/15/2024 Blackstone Inc.696,110$9.34M0.0%N/A2.612% (Data available from 1/1/2016 forward) LXEO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LXEO shares? During the previous two years, 61 institutional investors and hedge funds held shares of Lexeo Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($28.51M), Eventide Asset Management LLC ($16.78M), D1 Capital Partners L.P. ($14.50M), Artal Group S.A. ($12.57M), Novo Holdings A S ($10.15M), Blackstone Inc. ($9.34M), and Omega Fund Management LLC ($7.80M).Learn more on LXEO's institutional investors. What percentage of Lexeo Therapeutics stock is owned by institutional investors? 60.67% of Lexeo Therapeutics stock is owned by institutional investors. Learn more on LXEO's institutional investor holdings. Which institutional investors have been buying Lexeo Therapeutics stock? Of the 54 institutional investors that purchased Lexeo Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($3.00M), Omega Fund Management LLC ($2.16M), Affinity Asset Advisors LLC ($1.48M), Janus Henderson Group PLC ($1.39M), Frazier Life Sciences Management L.P. ($1.25M), Millennium Management LLC ($1.03M), and Point72 Asset Management L.P. ($750.24K). How much institutional buying is happening at Lexeo Therapeutics? Institutional investors have bought a total of 15,783,883 shares in the last 24 months. This purchase volume represents approximately $156.12M in transactions. Which Lexeo Therapeutics major shareholders have been selling company stock? Of the 16 institutional investors that sold Lexeo Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($2.36M), Eventide Asset Management LLC ($1.51M), Omega Fund Management LLC ($1.17M), Braidwell LP ($653.70K), Novo Holdings A S ($515.72K), D1 Capital Partners L.P. ($302.71K), and Frazier Life Sciences Management L.P. ($295.27K). How much institutional selling is happening at Lexeo Therapeutics? Institutional investors have sold a total of 7,092,764 shares in the last 24 months. This volume of shares sold represents approximately $48.40M in transactions. Related Companies Checkpoint Therapeutics Institutional Ownership SNDL Institutional Ownership Entrada Therapeutics Institutional Ownership Olema Pharmaceuticals Institutional Ownership Arcturus Therapeutics Institutional Ownership Heron Therapeutics Institutional Ownership Septerna Institutional Ownership Benitec Biopharma Institutional Ownership Fulcrum Therapeutics Institutional Ownership Atyr PHARMA Institutional Ownership This page (NASDAQ:LXEO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexeo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.